- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Biogen's revenue and net income 2007-2018
Biogen's revenue and net income 2007-2018
Biogen's revenue and net income from 2007 to 2018 (in million U.S. dollars)
by Matej Mikulic,
last edited
Feb 7, 2019
This statistic shows the revenue and net income of biotechnology company Biogen Idec from 2007 to 2018. Biogen Inc. is a Massachusetts-based biotech company, specialized in drugs for neurological disorders, autoimmune disorders and cancer. In 2018, Biogen Idec generated revenues worth around 13.5 billion U.S. dollars.
Biogen's revenue and net income from 2007 to 2018 (in million U.S. dollars)
Loading statistic...
| Total revenue | Net income | |
|---|---|---|
| 2018 | 13,452.9 | 4,474 |
| 2017 | 12,273.9 | 2,670.1 |
| 2016 | 11,448.8 | 3,695.7 |
| 2015 | 10,763.8 | 3,593.2 |
| 2014 | 9,703.3 | 2,941.5 |
| 2013 | 6,932.2 | 1,862.3 |
| 2012 | 5,516.5 | 1,380 |
| 2011 | 5,048.6 | 1,266.7 |
| 2010 | 4,716.4 | 898.6 |
| 2009 | 4,377.3 | 977.1 |
| 2008 | 4,097.5 | 790.1 |
| 2007 | 3,171.6 | 579.8 |
| Total revenue | Net income | |
|---|---|---|
| 2018 | 13,452.9 | 4,474 |
| 2017 | 12,273.9 | 2,670.1 |
| 2016 | 11,448.8 | 3,695.7 |
| 2015 | 10,763.8 | 3,593.2 |
| 2014 | 9,703.3 | 2,941.5 |
| 2013 | 6,932.2 | 1,862.3 |
| 2012 | 5,516.5 | 1,380 |
| 2011 | 5,048.6 | 1,266.7 |
| 2010 | 4,716.4 | 898.6 |
| 2009 | 4,377.3 | 977.1 |
| 2008 | 4,097.5 | 790.1 |
| 2007 | 3,171.6 | 579.8 |
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
by Matej Mikulic,
last edited
Feb 7, 2019
This statistic shows the revenue and net income of biotechnology company Biogen Idec from 2007 to 2018. Biogen Inc. is a Massachusetts-based biotech company, specialized in drugs for neurological disorders, autoimmune disorders and cancer. In 2018, Biogen Idec generated revenues worth around 13.5 billion U.S. dollars.
- Show sources information
- Show publisher information
- Release date
- February 2019
- Region
- Worldwide
- Survey time period
- 2007 to 2018
- Supplementary notes
- This statistic was assembled from several editions of Biogen's annual report.
- Open this statistic in...
Free access to basic statistics
Source
- Show sources information
- Show publisher information
- Release date
- February 2019
More information
- Region
- Worldwide
- Survey time period
- 2007 to 2018
- Supplementary notes
- This statistic was assembled from several editions of Biogen's annual report.
- Open this statistic in...
Other statistics on the topic
Biotechnology industry
+Pharmaceutical Products & Market
Top 50 pharmaceutical companies - Rx sales and R&D spending 2018
+Pharmaceutical Products & Market
Top global biotech companies based on market capitalization 2018
+Pharmaceutical Products & Market
Biogen's top products based on revenue 2016-2018
+Pharmaceutical Products & Market
Biogen's spending on research and development 2006-2018
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
All Information
in one Presentation
Biogen
- 39 page/s
- English
- pptx
- Detailed references
Everything On "Biogen" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
Other Reports & Dossiers
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.Marlene Greenfield
Vice President, Hearst Magazines
Statistics on "Biogen"
- Global positioning
The most important statistics
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2018 (in billion U.S. dollars)Top 50 pharmaceutical companies - Rx sales and R&D spending 2018
- Net sales of top global biotechnology companies in 2017/2018 (in million U.S. dollars)Top global biotech companies - net sales 2017/2018
- Top global biotechnology companies based on market capitalization as of 2018 (in billion U.S. dollars)Top global biotech companies based on market capitalization 2018
- Selected top biotechnology companies based on number of employees worldwide in 2017Top global biotech companies based on number of employees 2017
- Select top global biotechnology companies' R&D expenditure in 2017 (in million U.S. dollars)Top global biotech companies - R&D expenditure 2017
- Revenue/income
The most important statistics
- Biogen's revenue and net income from 2007 to 2018 (in million U.S. dollars)Biogen's revenue and net income 2007-2018
- Biogen's product revenue from 2016 to 2018, by therapeutic area (in million U.S. dollars)Biogen's product revenue 2016-2018, by therapeutic area
- Biogen's revenues in 2018, by type and region (in million U.S. dollars)Biogen's revenues in 2018, by type and region
- Biogen's top products from 2016 to 2018, based on revenue (in million U.S. dollars)Biogen's top products based on revenue 2016-2018
- Expenses/costs
The most important statistics
- Biogen's spending on research and development from 2006 to 2018 (in million U.S. dollars)Biogen's spending on research and development 2006-2018
- Biogen's total costs and expenses from 2014 to 2018 (in million U.S. dollars)Biogen's total costs and expenses 2014-2018
- Biogen's selling, general and administrative costs from 2016 to 2018 (in million U.S. dollars)Biogen's selling, general and administrative costs 2016-2018
- Other facts
The most important statistics
- Biogen's number of employees from 2014 to 2018Biogen's total staff 2014-2018
- Biogen's total assets from 2014 to 2018Biogen's total assets 2014-2018
- Earnings per Biogen share from 2014 to 2018 (in U.S. dollars)*Earnings per Biogen share 2014-2018
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Gilead Sciences' net income 2006-2018
- Net income of Bausch Health 2012-2018
- Celgene's revenue and net income 2006-2018
- Net income generated by NBTY 2009-2015
- Genentech: Net income
- Heska net income 2014 to 2018
- VECOL S.A.: net income 2016-2018
- Bristol-Myers Squibb's net income 2007-2018
- Brazil: net income of Raia Drogasil 2013-2016
- Qiagen net income 2012-2018
- European countries based on public biotech company net income 2010
- PerkinElmer net income 2012-2018
- Net income of Syneos Health 2013-2018
- Forbes selected biotech companies in China & Hong Kong 2017, based on net income
- Taisho Pharmaceutical's net income FY 2013 to 2017
- Brazil: net income of Mueller 2013-2017
- Helmerich & Payne's net income 2001-2018
- Net income of Alberta farms 2013-2018
- Empresas ICA net income 2014-2016
- Worldwide managed file transfer software revenue 2009-2013
Studies
- Biogen Inc. - 2018 Form 10-K
- Sobi Anual and sustainability report 2017
- Pharmaceutical industry in Italy
- Pharmaceutical trends in Europe
- Teva - 2018 Form 10-K
- PAGB Annual Review 2017-2018
- Biotechnology in Germany
- Novo Nordisk ANNUAL REPORT 2017
- Indicatori Farmaceutici
- Generic Pharmaceutical Industry Yearbook 2016
- Trends in Retail Prices of Prescription Drugs Widely Used by Older Americans, 2006 to 2013
- Celgene Corporation - 2018 Form 10-K
- Medtronic - 2019 Form 10-K
- Gilead Sciences - 2018 Form 10-K
- Boehringer Ingelheim - Annual Report 2018
Statistics on "Biogen"
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2018 (in billion U.S. dollars)
- Net sales of top global biotechnology companies in 2017/2018 (in million U.S. dollars)
- Top global biotechnology companies based on market capitalization as of 2018 (in billion U.S. dollars)
- Selected top biotechnology companies based on number of employees worldwide in 2017
- Select top global biotechnology companies' R&D expenditure in 2017 (in million U.S. dollars)
- Biogen's revenue and net income from 2007 to 2018 (in million U.S. dollars)
- Biogen's product revenue from 2016 to 2018, by therapeutic area (in million U.S. dollars)
- Biogen's revenues in 2018, by type and region (in million U.S. dollars)
- Biogen's top products from 2016 to 2018, based on revenue (in million U.S. dollars)
- Biogen's spending on research and development from 2006 to 2018 (in million U.S. dollars)
- Biogen's total costs and expenses from 2014 to 2018 (in million U.S. dollars)
- Biogen's selling, general and administrative costs from 2016 to 2018 (in million U.S. dollars)
- Biogen's number of employees from 2014 to 2018
- Biogen's total assets from 2014 to 2018
- Earnings per Biogen share from 2014 to 2018 (in U.S. dollars)*
- Gilead Sciences' net income from 2006 to 2018 (in million U.S. dollars)
- Net income of Bausch Health Companies from 2012 to 2018 (in million U.S. dollars)
- Revenue and net income of biotech company Celgene from 2006 to 2018 (in million U.S. dollars)
- Net income of NBTY from 2009 and 2015 (in million U.S. dollars)*
- Net income from biotech company Genentech from 2006 to 2008 (in million U.S. dollars)
- Heska's net income from 2014 to 2018 (in million U.S. dollars)
- Net income of VECOL S.A. from 2016 to 2018 (in billion Colombian pesos)
- Bristol-Myers Squibb's net income from 2007 to 2018 (in million U.S. dollars)*
- Net income of pharmacy network operator Raia Drogasil in Brazil from 2013 to 2016 (in million U.S. dollars)
- Net income of biotech company Qiagen from 2012 to 2018 (in million U.S. dollars)
- Leading European countries based on public biotech company net income in 2010 (in million euros)
- Net income of PerkinElmer from 2012 to 2018 (in million U.S. dollars)
- Syneos Health's net income from 2013 to 2018 (in million U.S. dollars)
- Leading companies in biotechnology and drugs in mainland China and Hong Kong according to Forbes in 2017, based on net income value (in million U.S. dollars)*
- Annual profit of Taisho Pharmaceutical Holdings Co., Ltd. from fiscal year 2013 to 2017 (in billion Japanese yen)*
- Net income of Mueller in Brazil from 2013 to 2017 (in million Brazilian reals)
- Net income of Helmerich & Payne from 2001 to 2018 (in 1,000 U.S. dollars)*
- Net income of farms in Alberta from 2013 to 2018 (in billion Canadian dollars)
- Consolidated net income of Empresas ICA from 2014 to 2016 (in billion Mexican pesos)
- Revenue of managed file transfer (MFT) software worldwide from 2009 to 2013 (in million U.S. dollars)
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Please log in to access our additional functions
Register in seconds and access exclusive features.
Basic Account
|
Instant Access
Premium Account
| ||
|---|---|---|---|
Our services
Click the question mark for further information | Free |
$49 per month*
| |
| Basic statistics | |||
| Premium statistics | |||
|
Graph download
| |||
| Download PDF | |||
|
Excel download
| |||
| Register | Purchase now | ||
*Duration: 12 months, billed annually, single license
Yes, let me download!
...and make my research life easier.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.